drugset / Trial / NCT00294567

Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)

NCT00294567

Phase 4 Completed 199 enrolled Juntendo University Japan Heart Foundation · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

In patients with hypertension who undergo elective PCI, the effects of long-term administration of Calblock (azelnidipine) on plaque volume will be determined quantitatively by 3D-IVUS and compared with those of amlodipine besilate (Norvasc or Amlodin).

Timeline

Start
2005-12
Primary completion
2009-05
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 5 mg
Comparator Azelnidipine Small molecule 16 mg